These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
287 related articles for article (PubMed ID: 26339394)
1. Heat shock protein 90-β over-expression is associated with poor survival in stage I lung adenocarcinoma patients. Wu Y; Huang B; Liu Q; Liu Y Int J Clin Exp Pathol; 2015; 8(7):8252-9. PubMed ID: 26339394 [TBL] [Abstract][Full Text] [Related]
2. Chaperone protein L-isoaspartate (D-aspartyl) O-methyltransferase as a novel predictor of poor prognosis in lung adenocarcinoma. Saito H; Yamashita M; Ogasawara M; Yamada N; Niisato M; Tomoyasu M; Deguchi H; Tanita T; Ishida K; Sugai T; Yamauchi K Hum Pathol; 2016 Apr; 50():1-10. PubMed ID: 26997432 [TBL] [Abstract][Full Text] [Related]
3. Prognostic impact of CD73 and A2A adenosine receptor expression in non-small-cell lung cancer. Inoue Y; Yoshimura K; Kurabe N; Kahyo T; Kawase A; Tanahashi M; Ogawa H; Inui N; Funai K; Shinmura K; Niwa H; Suda T; Sugimura H Oncotarget; 2017 Jan; 8(5):8738-8751. PubMed ID: 28060732 [TBL] [Abstract][Full Text] [Related]
4. Programmed Death Cell Ligand 1 (PD-L1) Is Associated With Survival in Stage I Non-Small Cell Lung Cancer. Sepesi B; Cuentas EP; Canales JR; Behrens C; Correa AM; Vaporciyan A; Weissferdt A; Kalhor N; Moran C; Swisher S; Wistuba I Semin Thorac Cardiovasc Surg; 2017 Autumn; 29(3):408-415. PubMed ID: 29195578 [TBL] [Abstract][Full Text] [Related]
5. Adipophilin expression in lung adenocarcinoma is associated with apocrine-like features and poor clinical prognosis: an immunohistochemical study of 328 cases. Fujimoto M; Yoshizawa A; Sumiyoshi S; Sonobe M; Menju T; Hirata M; Momose M; Date H; Haga H Histopathology; 2017 Jan; 70(2):232-241. PubMed ID: 27467545 [TBL] [Abstract][Full Text] [Related]
6. Elevated nuclear CCND1 expression confers an unfavorable prognosis for early stage lung adenocarcinoma patients. Xu P; Zhao M; Liu Z; Liu Y; Chen Y; Luo R; Fang W Int J Clin Exp Pathol; 2015; 8(12):15887-94. PubMed ID: 26884860 [TBL] [Abstract][Full Text] [Related]
7. Peroxiredoxin 4 as an independent prognostic marker for survival in patients with early-stage lung squamous cell carcinoma. Hwang JA; Song JS; Yu DY; Kim HR; Park HJ; Park YS; Kim WS; Choi CM Int J Clin Exp Pathol; 2015; 8(6):6627-35. PubMed ID: 26261544 [TBL] [Abstract][Full Text] [Related]
8. Clinicopathologic significance of TRAP1 expression in colorectal cancer: a large scale study of human colorectal adenocarcinoma tissues. Pak MG; Koh HJ; Roh MS Diagn Pathol; 2017 Jan; 12(1):6. PubMed ID: 28088229 [TBL] [Abstract][Full Text] [Related]
9. Clinical impact of immune microenvironment in stage I lung adenocarcinoma: tumor interleukin-12 receptor β2 (IL-12Rβ2), IL-7R, and stromal FoxP3/CD3 ratio are independent predictors of recurrence. Suzuki K; Kadota K; Sima CS; Nitadori J; Rusch VW; Travis WD; Sadelain M; Adusumilli PS J Clin Oncol; 2013 Feb; 31(4):490-8. PubMed ID: 23269987 [TBL] [Abstract][Full Text] [Related]
10. ROR1 is a novel prognostic biomarker in patients with lung adenocarcinoma. Zheng YZ; Ma R; Zhou JK; Guo CL; Wang YS; Li ZG; Liu LX; Peng Y Sci Rep; 2016 Nov; 6():36447. PubMed ID: 27830754 [TBL] [Abstract][Full Text] [Related]
12. Expression of caveolin-1 is correlated with disease stage and survival in lung adenocarcinomas. Zhan P; Shen XK; Qian Q; Wang Q; Zhu JP; Zhang Y; Xie HY; Xu CH; Hao KK; Hu W; Xia N; Lu GJ; Yu LK Oncol Rep; 2012 Apr; 27(4):1072-8. PubMed ID: 22200856 [TBL] [Abstract][Full Text] [Related]
13. Overexpression of CHD1L is positively associated with metastasis of lung adenocarcinoma and predicts patients poor survival. He LR; Ma NF; Chen JW; Li BK; Guan XY; Liu MZ; Xie D Oncotarget; 2015 Oct; 6(31):31181-90. PubMed ID: 26360781 [TBL] [Abstract][Full Text] [Related]
14. BAG-1/SODD, HSP70, and HSP90 are potential prognostic markers of poor survival in node-negative breast carcinoma. Davidson B; Valborg Reinertsen K; Trinh D; Reed W; Bøhler PJ Hum Pathol; 2016 Aug; 54():64-73. PubMed ID: 27038683 [TBL] [Abstract][Full Text] [Related]
15. The expression of TTF-1 and Napsin A in early-stage lung adenocarcinoma correlates with the results of surgical treatment. Ma Y; Fan M; Dai L; Kang X; Liu Y; Sun Y; Yan W; Liang Z; Xiong H; Chen K Tumour Biol; 2015 Sep; 36(10):8085-92. PubMed ID: 25982999 [TBL] [Abstract][Full Text] [Related]
16. Sox2 protein expression is an independent poor prognostic indicator in stage I lung adenocarcinoma. Sholl LM; Barletta JA; Yeap BY; Chirieac LR; Hornick JL Am J Surg Pathol; 2010 Aug; 34(8):1193-8. PubMed ID: 20631605 [TBL] [Abstract][Full Text] [Related]
17. Expression of CC chemokine receptor 9 predicts poor prognosis in patients with lung adenocarcinoma. Zhong Y; Jiang L; Lin H; Li B; Lan J; Liang S; Shen B; Lei Z; Zheng W Diagn Pathol; 2015 Jul; 10():101. PubMed ID: 26168791 [TBL] [Abstract][Full Text] [Related]
18. Elevated MACC1 expression predicts poor prognosis in small invasive lung adenocarcinoma. Guo T; Zhao S; Li Z; Li F; Li J; Gu C Cancer Biomark; 2018; 22(2):301-310. PubMed ID: 29630522 [TBL] [Abstract][Full Text] [Related]
19. Expression of HAb18G/CD147 and its localization correlate with the progression and poor prognosis of non-small cell lung cancer. Xu XY; Lin N; Li YM; Zhi C; Shen H Pathol Res Pract; 2013 Jun; 209(6):345-52. PubMed ID: 23602236 [TBL] [Abstract][Full Text] [Related]
20. Napsin A is an independent prognostic factor in surgically resected adenocarcinoma of the lung. Lee JG; Kim S; Shim HS Lung Cancer; 2012 Jul; 77(1):156-61. PubMed ID: 22418245 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]